Intelligent Investor
Sign up for free Sign up for free Sign up for free

Atomo Diagnostics Limited (ASX: AT1) - Share Price and Research

- Current share price for AT1 : $0.017

Atomo Diagnostics Limited (AT1), an ASX-listed company, is an Australian-headquartered medical device company supplying integrated rapid diagnostic test (RDT) devices to the global diagnostic market. Its patented devices simplify testing procedures, enhance usability and improve reliability across rapid point-of-care (POC) and at-home testing applications.

AT1 General Information +

ASX Code AT1
Website http://www.atomodiagnostics.com
Industry/Sector Health Care Equipment
Market Cap ($M) 11
AT1 Share Price $0.017
Day High $0.017
Day Low $0.017
Last Close $0.017
AT1 Share Price Movement - ( No change )
Prices as at 16:40, 19 May 2025
+Security prices are delayed by at least 20 minutes and are indicative only.
Upsell Banner

AT1 Related Research

Atomo Diagnostics Limited (AT1) Upcoming Dividends & Yields

There are no dividends for Atomo Diagnostics Limited (AT1). Please use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Atomo Diagnostics Limited (AT1) price-sensitive announcements

AT1 - Quarterly Activities/Appendix 4C Cash Flow Report
Atomo Diagnostics Limited reported a productive quarter with significant activity in its H
Atomo Diagnostics Limited (AT1)
24 Apr 2025 | 3:46 PM
AT1 - Atomo completes Capital Raise and undertakes Restructure
Atomo Diagnostics Limited has successfully completed a capital raise of up to $3.1 million
Atomo Diagnostics Limited (AT1)
24 Apr 2025 | 10:12 AM
AT1 - Trading Halt
Atomo Diagnostics Limited (ASX: AT1) has requested a trading halt of its securities as it
Atomo Diagnostics Limited (AT1)
22 Apr 2025 | 9:22 AM
AT1 - National Scale up of HIV Self-Test Vending Machines
Atomo Diagnostics Limited announced the national scale-up of free HIV self-tests through v
Atomo Diagnostics Limited (AT1)
7 Apr 2025 | 10:01 AM

See more price-sensitive ASX announcements or use our ASX Announcements tool to search for announcements across all ASX-listed securities.

Atomo Diagnostics Limited (AT1) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $12 Change in substantial holding 9 May 2025 4:27PM $0.017 $0.017 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $12 Final Director's Interest Notice x 3 5 May 2025 5:00PM $0.017 $0.017 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $12 Initial Director's Interest Notice x 2 5 May 2025 4:58PM $0.017 $0.017 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $12 Section 708A Cleansing Statement 5 May 2025 4:57PM $0.017 $0.017 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $12 Notification of cessation of securities - AT1 5 May 2025 4:56PM $0.017 $0.017 fallen by 0%
Atomo Diagnostics Limited (AT1)
ORDINARY FULLY PAID
Health Care $12 Notification regarding unquoted securities - AT1 5 May 2025 4:56PM $0.017 $0.017 fallen by 0%

AT1 Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2024A -$6.05 -$1.00 -45.40% 0.00 0.00 0.00% 0.0%
2023A -$9.96 -$1.70 74.00% 0.00 0.00 0.00% 0.0%
2022A -$5.71 -$1.00 -6.50% 0.00 0.00 0.00% 0.0%

AT1 Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2022 A 2023 A 2024 A 2022 A 2023 A 2024 A 2022 A 2023 A 2024 A
Atomo Diagnostics (AT1) $12M -0.4540 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Cochlear (COH) $17,551M 0.2705 0.0615 0.1130 45.6157 42.9738 38.6103 1.53% 1.63% 1.81%
Fisher & Paykel Hlth (FPH) $19,985M -0.4850 1.6561 0.1811 164.4477 61.9143 52.4220 1.12% 1.17% 1.29%
ResMed (RMD) $22,758M -0.8795 10.8488 0.1115 350.9451 29.6187 26.6471 0.76% 0.78% 0.88%

AT1 Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.08 0.00
Market 0.24 13.60 1.08 1.02
Sector 0.90 25.30 1.82 1.63

AT1 Directors

Name Position Start Date
Mr John Michael Kelly Founder, Chief Executive Officer, Managing Director 1 Apr 2010
Dr Cheri Louise Walker Non-Executive Director 15 Nov 2022
Mr Anthony May Non-Executive Director 2 May 2025
Mr Patrick Cook Non-Executive Director 2 May 2025

Atomo Diagnostics Limited (AT1) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
27 Oct 2022 KELLY, John Issued Options 666,666 $0.020 $13,333.320
3 Nov 2021 KELLY, John Sell Indirect Shares 1,040,000 $0.276 $286,896.100
9 Apr 2021 LABELLE, Curt Exercise Options 960,000 $0.156 $150,000.000

See all changes in directors' interest & trades for Atomo Diagnostics Limited (AT1) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

AT1 Management

Name Position
Mathew Leslie Watkins Company Secretary

AT1 Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Atomo Diagnostics Limited (AT1). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
79,787,536 (12.48%) GZ Family Holdings Pty Ltd
72,490,248 (11.34%) John Kelly
64,811,280 (10.14%) Global Health Investment Fund I LLC

FAQs about Atomo Diagnostics Limited (AT1)

Atomo Diagnostics Limited's (AT1) current share price is $0.02. This constitutes a price movement of 3.03% when compared to the share price 7 days ago and is -45.16% below AT1's 12-month high of $0.03 per share. Prices are delayed by at least 20 minutes.

Relative to the previous close share price of $0.02, Atomo Diagnostics Limited's (AT1) current share price of $0.02 constitutes a movement of or 0%. Atomo Diagnostics Limited's (AT1) share price movement is 3.03% when compared to 7 days ago and is -45.16% below AT1's 52-week high of $0.03.

Atomo Diagnostics Limited's (AT1) 52-week high is $0.03 which was reached on 23 May 2024. Relative to this, AT1's current share price of $0.02 constitutes a -$0.01 or -45.16% drop since that high of $0.03 per AT1 share.

Atomo Diagnostics Limited's (AT1) 52-week low is $0.02 which was reached on 1 Apr 2025. Relative to this, AT1's current share price of $0.02 constitutes a $0.00 or 6.25% gain since that low of $0.02 per AT1 share.

Over the last 12 months, Atomo Diagnostics Limited (AT1) has a daily average trading volume of 311,846 AT1 shares per day.

Atomo Diagnostics Limited (AT1) has a current dividend yield of n/a this year. Last year's dividend yield was 0%. The dividend yield for AT1 is a ratio that tells you the percentage of Atomo Diagnostics Limited's (AT1) share price that it pays out in dividends each year.

Atomo Diagnostics Limited (AT1) will release its next Annual Report on n/a. Atomo Diagnostics Limited's (AT1) last annual report was released on 29 Aug 2024. Click here to view Atomo Diagnostics Limited's (AT1) last annual report.

Atomo Diagnostics Limited (AT1) is classified as Health Care. Other companies in this sector include CSL Limited (CSL), Sigma Healthcare Limited (SIG), Pro Medicus Limited (PME), and ResMed Inc. (RMD).

The price-to-earnings (P/E) ratio for Atomo Diagnostics Limited (AT1) is 0. The price-to-earnings ratio, also known as P/E ratio, P/E, or PER, is the ratio of Atomo Diagnostics Limited's (AT1) share price to its earnings per AT1 share.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.